Pharmaceutical, Murzi (J&J): "In Italy over 127 Active Clinical Trials and 7,500 Patients Involved"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.7 Articles
7 Articles
canaledieci.it
It is important to celebrate 50 years and see everything that has been the development of our company in Italy. But above all, in a perspective of future reasoning, think about the next 50 years and understand how our company can help the Italian system and patients find answers for all the [...]
notizie.it
Rec News | Lontani dal mainstream(Adnkronos) - "It is important to celebrate 50 years and see everything that has been the development of our company in Italy. But above all, with a view to
In collaboration with Il Sole 24 hours we receive and publish the link of the following news. Opinione thanks the publisher for the multimedia partnership. /// Build for the pharmaceutical a regulatory framework that allows to reconcile three objectives: sustainability of the SSN, ability to develop and introduce therapeutic innovation and competitiveness of one of the most... Link to the [...]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
